Toggle light / dark theme

While his neighbors frantically fled from their oncoming doom, one man stayed in bed. For whatever reason, he didn’t join the other 2000 residents of Herculaneum—the ancient Roman city just north of Pompeii—as they ran from erupting Mount Vesuvius. The first scorching cloud of ash passed through the city so quickly, it turned his brain into black, glasslike shards. Now, a new analysis of these shards, published today in, offers clues about how the man and his neighbors perished in 79 C.E.

Until recently, scientists believed the people of Herculaneum were annihilated by Mount Vesuvius’s avalanche of hot rock, ash, and gas that buried their city, along with Pompeii. But when researchers announced the discovery of those black, glossy chips in 2020, a new culprit emerged: a swift ash cloud preceding this flood of debris. This rethink, however, hinged on whether the brain had indeed turned to glass.

For glass to form, a liquid needs to be cooled so rapidly that its molecules suddenly “freeze” into a rigid structure rather than forming crystals. For this reason, glass is sometimes referred to as a “liquid solid,” says Brian Wowk, a cryobiologist at 21st Century Medicine who was not involved with the work. Thick blankets of pyroclastic flow–the torrent of rocks, ash, and gas expelled by volcanos–cool off far too slowly for glass to form, says study co-author Guido Giordano, a volcanologist at the Roma Tre University. “Once they’re in place, they can take years to cool down.”

New radio telescopes like ASKAP and MeerKAT are unveiling a ‘low surface brightness Universe’, enhancing our understanding of its hidden features.


Radio astronomers see what the naked eye can’t. As we study the sky with telescopes that record radio signals rather than light, we end up seeing a lot of circles.

The newest generation of radio telescopes – including the Australian Square Kilometre Array Pathfinder (ASKAP) and MeerKAT, a telescope in South Africa – is revealing incredibly faint cosmic objects, never before seen.

In astronomy, surface brightness is a measure that tells us how easily visible an object is. The extraordinary sensitivity of MeerKAT and ASKAP is now revealing a new “low surface brightness universe” to radio astronomers.

Experts say the creature looks just like a floating buttocks.

Deep beneath the ocean’s surface, in the Midnight Zone where no sunlight reaches, scientists have discovered a peculiar creature.

Known as the pigbutt worm, Chaetopterus pugaporcinus was first spotted in 2001 off the coast of California. This translucent, marble-sized blob immediately baffled researchers.

Its rounded shape and distinctive lobes earned it the humorous nickname, as it amusingly resembles a pig’s behind. Marine biologists have since identified it as a type of bristle worm, though its exact life stage—whether adult or larval—remains uncertain. Unlike most of its relatives, which burrow into the seafloor, this worm floats freely in the water column, showcasing an unusual adaptation known as neoteny, where juvenile traits persist into adulthood.

Beyond its quirky appearance, the pigbutt worm possesses remarkable survival skills. Scientists have observed it generating mucus nets to trap marine snow and organic debris for sustenance. Even more astonishingly, it glows in the dark—flashing blue bioluminescence when disturbed, while its mucus net sometimes emits green light, likely as a defense mechanism against predators.

Decades after its discovery, this deep-sea enigma continues to fascinate researchers, serving as a reminder of the vast, unexplored wonders of the ocean. As marine biologist Rebecca Helm puts it, studying the deep sea feels like planetary exploration—proof that some of Earth’s most alien creatures are right here in our own waters.

Learn more.

OpenAI is betting big on ChatGPT, which is generating at least $4 billion in annualized revenue. But that’s not the only application the AI firm is hoping will make big bucks. If you saw our story last month detailing OpenAI’s financial projections, you might have noticed an intriguing reference…

The hippocampus is essential for episodic memory, yet its coding mechanism remains debated. In humans, two main theories have been proposed: one suggests that concept neurons represent specific elements of an episode, while another posits a conjunctive code, where index neurons code the entire episode. Here, we integrate new findings of index neurons in humans and other animals with the concept-specific memory framework, proposing that concept neurons evolve from index neurons through overlapping memories. This process is supported by engram literature, which posits that neurons are allocated to a memory trace based on excitability and that reactivation induces excitability. By integrating these insights, we connect two historically disparate fields of neuroscience: engram research and human single neuron episodic memory research.

For decades, exercise was considered an optional part of cancer care—something beneficial for general health but not essential. The evidence is now overwhelming: exercise is not just supportive—it’s a therapeutic intervention that recalibrates tumor biology, enhances treatment tolerance, and improves survival outcomes.

With over 600 peer-reviewed studies, Dr. Kerry Courneya’s work has fundamentally reshaped our understanding of how structured exercise—whether aerobic, resistance training, or high-intensity intervals—can mitigate treatment side effects, enhance immune function, and directly influence cancer progression.

Train smarter with evidence-based strategies from top experts—get your free copy of “How to Train According to the Experts” at https://howtotrainguide.com/

CHAPTERS:
00:00:00 Introduction.
00:01:47 Why exercise should be effortful.
00:02:33 How to meaningfully reduce risk of cancer.
00:06:22 What type of exercise is best?
00:07:59 How exercise reduces risk—even for smokers and the obese.
00:10:48 Weekend-only exercise.
00:13:49 150 vs. 300 minutes per week (more is better—up to a point)
00:16:03 Why pre-diagnosis exercise matters.
00:19:09 Why resilience to cancer treatment starts with exercise.
00:21:01 Why low muscle mass drives cancer death.
00:23:58 Why BMI fails to measure true obesity.
00:27:51 Why daily activity isn’t enough (structured exercise matters)
00:29:34 Breaking up sedentary time—do ‘exercise snacks’ help?
00:31:50 Supplements vs. exercise.
00:32:32 Where exercise fits with chemo and immunotherapy.
00:35:30 Why rest is not the best medicine.
00:41:20 Aerobic vs. resistance.
00:42:11 How chemotherapy patients were able to put on over a kilogram of muscle.
00:42:13 How weight training improves ‘chemo completion’
00:44:41 Why exercise creates vulnerability in cancer cells (limitations do apply)
00:47:09 Why exercise might be crucial for tumor elimination.
00:53:03 Why cardio may be better at clearing tumor cells.
00:56:18 When cancer spreads quickly—and when it doesn’t.
00:57:43 Why liquid biopsies may prevent over-treatment.
01:02:56 Exercise-sensitive vs. exercise-resistant cancers.
01:06:06 Prostate cancer therapy—why strength training matters.
01:08:10 When exercise is the only therapy—does it work?
01:09:26 Why HIIT reduces PSA in prostate cancer.
01:11:40 Avoiding over-treatment—can exercise buy you time?
01:12:00 Why high-intensity exercise boosts anti-cancer biology.
01:13:11 Turning a diagnosis into a wake-up call.
01:16:11 Why oncologists are rethinking exercise.
01:18:50 Why exercise eases anxiety about cancer—proven psychological benefits.
01:25:00 Before, during, and after treatment.
01:27:02 Why exercise is unique among cancer therapies.
01:28:16 Why cancer patients stop exercising—the risky mistake almost everyone makes.
01:30:41 How to get sedentary cancer patients exercising (realistically)
01:33:15 The $1 million case for including exercise.
01:34:56 Why recurrence trials haven’t convinced doctors—yet.
01:37:36 The bottom-line message.
01:37:55 The myth of a cancer panacea (exercise included)
01:44:07 What’s the best $50 investment for staying active?
01:44:40 Only 15 minutes per day—what’s the best anti-cancer exercise?

A quick cautionary note: Always consult a qualified healthcare provider—presumably an oncologist if your questions involve cancer treatment—particularly if you’re considering actions based on or inspired by our conversation today. This episode should not be construed as a substitute for qualified medical advice.

*Kerry Courneya, PhD*